W. Dickey et al., EFFECT OF PROTON PUMP INHIBITORS ON THE DETECTION OF HELICOBACTER-PYLORI IN GASTRIC BIOPSIES, Alimentary pharmacology & therapeutics, 10(3), 1996, pp. 289-293
Background: Proton pump inhibitors are known to decrease the activity
of Helicobacter pylori organisms within the stomach and to shift their
distribution proximally. This effect may reduce the sensitivity of hi
stological examination and rapid urease testing for H. pylori on biops
ies taken from recommended sites. It is of particular relevance if a p
roton pump inhibitor has been prescribed before the patient has underg
one diagnostic endoscopy. Methods: We studied patients referred to our
open-access upper gastrointestinal endoscopy service who had either b
een on no medication (controls) or were already taking proton pump inh
ibitors. Biopsies taken from the gastric antrum and corpus were used f
or rapid urease testing and for histological examination. Sera, taken
from patients who had no evidence of H. pylori in biopsies, were teste
d for IgG H. pylori antibodies as an alternative indicator of infectio
n. Results: H. pylori organisms were detected by histological examinat
ion in 27 of 40 controls (68%) and in 13 of 25 patients taking proton
pump inhibitors (52%). Among patients with positive histology (organis
ms detected in either antral or corpus biopsies, or both), only the se
nsitivity of the antral urease test read at 1 h was significantly lowe
r in patients taking proton pump inhibitors than in controls, with no
significant difference in sensitivities of the antral urease test at 2
4 h, of the corpus urease test at 1 or 24 h, or of histology from the
antrum or corpus. Of patients with negative histology, none of 13 cont
rols compared with six of 12 patients taking proton pump inhibitors (5
0%) had positive serology (P = 0.005). Five (83%) of the six histology
-negative, seropositive patients taking proton pump inhibitors had his
tological changes consistent with H. pylori gastritis even though no o
rganisms were detected. Conclusions: Treatment with a proton pump inhi
bitor before endoscopy reduces the sensitivity of antral and corpus bi
opsies for H. pylori detection, both by urease testing and histologica
l examination. If proton pump inhibitors already prescribed cannot be
discontinued for an adequate period before endoscopy, patients should
have biopsies taken from the corpus as well as from the antrum, and se
rum should be tested for H. pylori.